Analysis of Parainflammation in Chronic Glaucoma Using Vitreous-OCT Imaging
María Jesús Rodrigo,
Manuel Subías,
Alberto Montolío,
Silvia Méndez-Martínez,
Teresa Martínez-Rincón,
Lorena Arias,
David García-Herranz,
Irene Bravo-Osuna,
Julian Garcia-Feijoo,
Luis Pablo,
José Cegoñino,
Rocio Herrero-Vanrell,
Ana Carretero,
Jesus Ruberte,
Elena Garcia-Martin,
Amaya Pérez del Palomar
Affiliations
María Jesús Rodrigo
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Manuel Subías
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Alberto Montolío
Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain
Silvia Méndez-Martínez
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Teresa Martínez-Rincón
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Lorena Arias
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
David García-Herranz
Innovation, Therapy and Pharmaceutical Development in Ophthalmology (InnOftal) Research Group, UCM 920415, Department of Pharmaceutics and Food Technology, Faculty of Pharmacy, Complutense University of Madrid (UCM), 28040 Madrid, Spain
Irene Bravo-Osuna
University Institute of Industrial Pharmacy (IUFI), School of Pharmacy, Complutense University of Madrid, 28040 Madrid, Spain
Julian Garcia-Feijoo
Department of Ophthalmology, San Carlos Clinical Hospital, UCM, 28040 Madrid, Spain
Luis Pablo
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
José Cegoñino
Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain
Rocio Herrero-Vanrell
National Ocular Pathology Network (OFTARED), Carlos III Health Institute, 28040 Madrid, Spain
Ana Carretero
Centre for Animal Biotechnology and Gene Therapy (CBATEG), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
Jesus Ruberte
Centre for Animal Biotechnology and Gene Therapy (CBATEG), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain
Elena Garcia-Martin
Department of Ophthalmology, Miguel Servet University Hospital, 50009 Zaragoza, Spain
Amaya Pérez del Palomar
Biomaterials Group, Aragon Engineering Research Institute (I3A), University of Zaragoza, 50018 Zaragoza, Spain
Glaucoma causes blindness due to the progressive death of retinal ganglion cells. The immune response chronically and subclinically mediates a homeostatic role. In current clinical practice, it is impossible to analyse neuroinflammation non-invasively. However, analysis of vitreous images using optical coherence tomography detects the immune response as hyperreflective opacities. This study monitors vitreous parainflammation in two animal models of glaucoma, comparing both healthy controls and sexes over six months. Computational analysis characterizes in vivo the hyperreflective opacities, identified histologically as hyalocyte-like Iba-1+ (microglial marker) cells. Glaucomatous eyes showed greater intensity and number of vitreous opacities as well as dynamic fluctuations in the percentage of activated cells (50–250 microns2) vs. non-activated cells (10–50 microns2), isolated cells (10 microns2) and complexes (>250 microns2). Smaller opacities (isolated cells) showed the highest mean intensity (intracellular machinery), were the most rounded at earlier stages (recruitment) and showed the greatest change in orientation (motility). Study of vitreous parainflammation could be a biomarker of glaucoma onset and progression.